SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-105169
Filing Date
2021-08-13
Accepted
2021-08-13 16:48:00
Documents
78
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q scps-20210630x10q.htm   iXBRL 10-Q 1280628
2 EXHIBIT 10.18 scps-20210630xex10d18.htm EX-10.18 157851
3 EXHIBIT 10.19 scps-20210630xex10d19.htm EX-10.19 402627
4 EXHIBIT 10.20 scps-20210630xex10d20.htm EX-10.20 375334
5 EXHIBIT 31.1 scps-20210630xex31d1.htm EX-31.1 14156
6 EXHIBIT 31.2 scps-20210630xex31d2.htm EX-31.2 14438
7 EXHIBIT 32.1 scps-20210630xex32d1.htm EX-32.1 6590
8 EXHIBIT 32.2 scps-20210630xex32d2.htm EX-32.2 6361
  Complete submission text file 0001104659-21-105169.txt   6441716

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA scps-20210630.xsd EX-101.SCH 61697
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scps-20210630_cal.xml EX-101.CAL 31550
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scps-20210630_def.xml EX-101.DEF 186629
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE scps-20210630_lab.xml EX-101.LAB 436253
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scps-20210630_pre.xml EX-101.PRE 358759
14 EXTRACTED XBRL INSTANCE DOCUMENT scps-20210630x10q_htm.xml XML 693881
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39788 | Film No.: 211173009
SIC: 2834 Pharmaceutical Preparations